Skip to main content
iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
7.85
-0.05 (-0.63%)
At close: Nov 20, 2024, 4:00 PM
7.87
+0.02 (0.25%)
After-hours: Nov 20, 2024, 5:17 PM EST

iTeos Therapeutics Revenue

iTeos Therapeutics had revenue of $35.00M in the twelve months ending September 30, 2024, down -47.37% year-over-year. In the year 2023, iTeos Therapeutics had annual revenue of $12.60M, down -95.29%.

Revenue (ttm)
$35.00M
Revenue Growth
-47.37%
P/S Ratio
8.66
Revenue / Employee
$222,930
Employees
157
Market Cap
286.79M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202312.60M-255.04M-95.29%
Dec 31, 2022267.63M-77.15M-22.38%
Dec 31, 2021344.78M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accolade 441.03M
AngioDynamics 292.73M
OraSure Technologies 224.26M
Vanda Pharmaceuticals 190.86M
Voyager Therapeutics 163.78M
Sage Therapeutics 106.40M
NeuroPace 76.45M
Revenue Rankings

ITOS News

More News